The FDA assessed the safety and efficiency of atidarsagene autotemcel determined by info from 37 small children who obtained atidarsagene autotemcel in two single-arm, open-label medical trials As well as in an expanded entry application.[seven] Kids who acquired cure with atidarsagene autotemcel were being in comparison with untreated small childr